DARLA NORRIS: Open Payments
NPI 1083295117 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,000 in 212 payments from 31 companies in 2025. Trend: 2023 $3,149 · 2024 $3,498 · 2025 $4,000
Food & beverage: $3,821Education: $178
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 31 | $749 |
| GENZYME CORPORATION | 25 | $633 |
| UCB, Inc. | 12 | $250 |
| Verona Pharma, Inc. | 16 | $240 |
| Regeneron Healthcare Solutions, Inc. | 9 | $194 |
| ABBVIE INC. | 18 | $170 |
| SANOFI-AVENTIS U.S. LLC | 2 | $170 |
| Vanda Pharmaceuticals Inc. | 21 | $169 |
| ARS Pharmaceuticals Operations, Inc. | 10 | $169 |
| CSL Behring | 9 | $159 |
Products named: DUPIXENT, FASENRA, Bimzelx, Ohtuvayre, FANAPT, NEFFY, SAPHNELO, Hizentra.
Industry payments across OK — which companies pay providers there.
